NASDAQ:ETON - Eton Pharmaceuticals Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$6.00 -0.01 (-0.17 %)
(As of 12/16/2018 01:20 PM ET)
Previous Close$6.00
Today's Range$6.00 - $6.09
52-Week Range$5.90 - $6.68
Volume10,525 shs
Average Volume19,483 shs
Market Capitalization$101.51 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical product using the U.S. Food and Drug Administration's 505(b)(2) regulatory pathway. It primarily focuses on liquid products, including injectable, oral liquid, and ophthalmic products. The company is developing DS-300, an injectable nutrition product candidate; EM-100, an ophthalmic product for the treatment of allergic conjunctivitis; ET-103, an oral liquid product candidate; DS-100, an injectable product candidate for use in pain management; DS-200, an injectable parenteral nutrition product candidate; ET-101, an oral liquid product for use in seizure control; ET-102, an oral liquid product for use as a muscle relaxant; and CT-100, a synthetic corticotropin therapeutic candidate that mimics the amino acid chain of H.P. Acthar Gel. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.

Receive ETON News and Ratings via Email

Sign-up to receive the latest news and ratings for ETON and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:ETON
Previous Symbol
CUSIPN/A
Phone858-704-4040

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees10
Outstanding Shares16,920,000
Market Cap$101.51 million
OptionableNot Optionable

Eton Pharmaceuticals (NASDAQ:ETON) Frequently Asked Questions

What is Eton Pharmaceuticals' stock symbol?

Eton Pharmaceuticals trades on the NASDAQ under the ticker symbol "ETON."

Has Eton Pharmaceuticals been receiving favorable news coverage?

Media stories about ETON stock have trended positive recently, InfoTrie Sentiment reports. InfoTrie scores the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Eton Pharmaceuticals earned a news impact score of 3.0 on InfoTrie's scale. They also gave headlines about the company a news buzz of 8.0 out of 10, indicating that recent news coverage is very likely to have an impact on the stock's share price in the next few days.

Who are some of Eton Pharmaceuticals' key competitors?

Who are Eton Pharmaceuticals' key executives?

Eton Pharmaceuticals' management team includes the folowing people:
  • Mr. Sean E. Brynjelsen, Pres, CEO & Director (Age 46)
  • Mr. W. Wilson Troutman CPA, CFO, Treasurer & Sec. (Age 63)

When did Eton Pharmaceuticals IPO?

(ETON) raised $22 million in an initial public offering on Wednesday, November 14th 2018. The company issued 3,600,000 shares at a price of $6.00 per share. National Securities Corporation served as the underwriter for the IPO.

When does Eton Pharmaceuticals' quiet period expire?

Eton Pharmaceuticals' quiet period expires on Monday, December 24th. Eton Pharmaceuticals had issued 3,600,000 shares in its initial public offering on November 13th. The total size of the offering was $21,600,000 based on an initial share price of $6.00. During Eton Pharmaceuticals' quiet period, insiders and any underwriters involved in the IPO are restricted from issuing any research reports for the company because of SEC regulations. Following the end of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

How do I buy shares of Eton Pharmaceuticals?

Shares of ETON can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Eton Pharmaceuticals' stock price today?

One share of ETON stock can currently be purchased for approximately $6.00.

How big of a company is Eton Pharmaceuticals?

Eton Pharmaceuticals has a market capitalization of $101.51 million. Eton Pharmaceuticals employs 10 workers across the globe.

What is Eton Pharmaceuticals' official website?

The official website for Eton Pharmaceuticals is http://www.etonpharma.com.

How can I contact Eton Pharmaceuticals?

Eton Pharmaceuticals' mailing address is 12264 EL CAMINO REAL, SAN DIEGO CA, 92130. The company can be reached via phone at 858-704-4040 or via email at [email protected]


MarketBeat Community Rating for Eton Pharmaceuticals (NASDAQ ETON)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  3 (Vote Outperform)
Underperform Votes:  5 (Vote Underperform)
Total Votes:  8
MarketBeat's community ratings are surveys of what our community members think about Eton Pharmaceuticals and other stocks. Vote "Outperform" if you believe ETON will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ETON will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/16/2018 by MarketBeat.com Staff

Featured Article: Net Asset Value (NAV)

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel